As the U.S. inches closer to the summer traveling season, the Federal Aviation Administration is looking to avoid another season of mass delays.

A shortage in air traffic controllers and overall staffing at airports caused multiple travel delays since the early days of the pandemic. As a fix, the FAA is implementing a few guidelines it hopes will make flying a bit more seamless. 

In New York City and Washington, DC, airlines will have reduced flight slot requirements during takeoffs and landings in an effort to cut down congestion. Slots provide airlines the right to enter and exit specific airports at designated times.

Despite the plan, the agency said it still expects the rate of delays to jump 45 percent from 2022.

The FAA is also leaning on airlines to help navigate the delay issue and will host a brainstorming summit. 

Delta Airlines said it supports the agency's efforts to clear up congestion at airports.

"Delta is reviewing our network to ensure the best customer experience throughout the summer travel season, and we are committed to working with the FAA on measures to ensure the safety and efficiency of operations at the NY/NJ airports," the airlines stated according to CNBC.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More